# DESCRIPTION

## BACKGROUND OF THE INVENTION

- describe DNA repair mechanisms

## SUMMARY OF THE INVENTION

- introduce HDR enhancement methods
- describe vector compositions
- outline methods for HDR enhancement

## DETAILED DESCRIPTION

### Definitions

- define technical and scientific terms
- introduce terminology for the invention
- define "autologous" and "allogeneic"
- define "bp" and "complementary"
- introduce CRISPR/Cas and CRISPR/Cas9 systems
- define "endogenous" and "exogenous"
- introduce "expression" and "expression vector"
- define "homologous" and "identity"
- introduce "instructional material" and "isolated"
- define "lentivirus" and "modified"

### Description

- describe CRISPR systems and gene editing processes

### Compositions

- define dgRNA composition
- describe activation plasmid/vector
- describe repression plasmid/vector
- describe inducible repression and activation plasmids/vectors
- describe traffic light reporter plasmid/vector

### Methods

- describe methods for increasing homology directed repair (HDR) and/or decreasing non-homologous end joining (NHEJ) in a cell
- outline method of enhancing HDR and/or decreasing DNA NHEJ following CRISPR editing in a cell using Cas9, sgRNA, activation plasm
- outline method of enhancing HDR and/or decreasing DNA NHEJ following CRISPR editing in a cell using Cas9, sgRNA, repression plasm
- outline method of enhancing HDR and/or decreasing DNA NHEJ following CRISPR editing in a cell using Cas9, sgRNA, activation plasm
- outline method of enhancing HDR and/or decreasing DNA NHEJ following CRISPR editing in a cell using Cas9, sgRNA, repression plasm
- describe design of activation plasmid and repression plasmid
- describe design of sgRNAs
- describe administration of plasmids to an animal
- describe CRISPR/Cas9 system
- introduce biological methods for introducing polynucleotides into host cells
- describe chemical means for introducing polynucleotides into host cells
- motivate use of RNA as nucleic acid
- describe production of RNA by in vitro transcription
- discuss modification of RNA for stability and translation efficiency
- describe methods for introducing RNA into cells
- motivate use of electroporation for RNA delivery
- describe sources of cells for RNA transfection
- discuss methods for isolating and storing cells

### Pharmaceutical Compositions

- formulate pharmaceutical compositions
- administer pharmaceutical compositions

## Experimental Examples

- describe materials and methods employed in experiments
- outline cell culture and transient transfection procedures
- detail lentivirus production and transduction methods
- summarize RT-qPCR, confocal fluorescence imaging, and flow cytometry analysis procedures

### Example 1

- introduce CRISPRa/i method for enhancing HDR efficiency
- describe construction of dgRNA-MS2:MPH and dgRNA-Com:CK plasmids
- outline TLR reporter system for quantifying HDR and NHEJ events
- detail experiments testing HDR efficiency enhancement using dgRNA-MS2:MPH and dgRNA-Com:CK
- summarize results showing enhanced HDR efficiency with CRISPRa/i programming

### Other Embodiments

- define scope of embodiments

